Elutia is a biotechnology company based in Silver Spring, Maryland, employing 54 people and specializing in Device Protection, Women’s Health, and Cardiovascular products. It went public on October 8, 2020, selling innovative medical solutions such as CanGaroo and SimpliDerm.
Elutia (ELUT) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Elutia's actual EPS was -$0.33, beating the estimate of -$0.45 per share, resulting in a 26.47% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
